|
|
||||||||
From the Departments of Neurology (Drs. Goldstein, Ashley, Freedman, and Levey) and Pathology (Dr. Gearing), Emory University School of Medicine; Department of Biostatistics (Dr. Hanfelt), Emory University; and the Neuroscience Institute (Dr. Penix), Morehouse School of Medicine, Atlanta, GA.
Address correspondence and reprint requests to Dr. F.C. Goldstein, Department of Neurology, Emory University School of Medicine, 1841 Clifton Road N.E., Atlanta, GA 30329; e-mail: fgoldst{at}emory.edu
The authors examined whether the APOE-
4 allele is associated with an earlier age at onset of AD in 71 African American patients with probable AD. The authors found a linear dose effect in which each copy of the
4 allele was associated with a 3.6-year earlier onset of AD, indicating a dose-dependent relationship between APOE-
4 and age at onset of AD in African Americans.
This article has been cited by other articles:
![]() |
S. Y. Moody-Ayers, K. M. Mehta, K. Lindquist, L. Sands, and K. E. Covinsky Black-White Disparities in Functional Decline in Older Persons: The Role of Cognitive Function J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(7): 933 - 939. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |